Rodenticides Market Investment Outlook and Trend Forecast 2026–2034

`

The global rodenticides market size was valued at USD 2.04 billion in 2019 and is projected to reach USD 3.10 billion by 2032, growing at a CAGR of 3.30% during the forecast period. The market is primarily driven by rising urbanization, escalating public health concerns linked to rodent-borne diseases, and significant agricultural losses caused by rodent infestations worldwide.

Key Growth Drivers

1. Rising Incidence of Rodent-Borne Diseases Rodents are associated with approximately 60 diseases globally, including plague, typhus, and Hantavirus. The threat posed by these diseases to public health has significantly accelerated the adoption of rodenticides across residential, commercial, and industrial sectors.
2. Increasing Agricultural Damage More than 20% of all food produced globally is damaged by rodents. Countries like India have recorded over 57,676 metric tons of food grains spoiled due to rodent and pest attacks in FCI (Food Corporation of India) godowns alone. This severe economic and food security threat is a key driver for rodenticide demand.
3. Growing Urbanization and Industrialization Rapid urban expansion has led to rodent displacement into human settlements. Expanding residential areas and commercial zones are creating pressure on governments and property owners to maintain hygiene standards, further fueling market demand.
4. Integrated Pest Management (IPM) Practices The growing adoption of IPM programs — which emphasize long-term rodent prevention through comprehensive management approaches — is encouraging structured and sustained use of rodenticides in combination with other control measures.

Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/rodenticides-market-102826

Market Segmentation

By Type:

• Anticoagulants dominate with a projected 75.54% market share, owing to their effectiveness, low toxicity to non-target species, and the absence of bait shyness in rodents. First-generation anticoagulants (chlorophacinone, diphacinone) and second-generation variants (flocoumafen, bromadiolone) are widely used.
• Non-anticoagulants are gaining traction in agricultural applications due to their rapid action on rodents.

By Form:

• Pellets are the most popular formulation, valued for cost-effectiveness and high attractiveness to rodents. Other forms include blocks, powders, sprays, liquids, and granules.

By Application:

• Pest Control Companies hold the largest share, as licensed applicators are increasingly preferred for safe and professional rodent management.
• Agricultural Fields and Warehouses are other significant application segments, driven by persistent crop and stored-grain damage caused by rodents.

Regional Analysis

North America leads the global market with a 33.95% share in 2019. The U.S. is projected to reach USD 736.31 million by 2032, supported by a high rodent population, growing residential construction, and strong regulatory frameworks for pest management.

Europe follows, driven by stricter hygiene regulations, aging drainage infrastructure, and rising rodent-borne disease awareness. Countries like Germany are adopting integrated pest management approaches.

Asia Pacific is the fastest-growing region, propelled by the central role of agriculture in economies like China and India, rapid population growth, and the affordability and ease of use of rodenticides in emerging markets.

South America, particularly Brazil, is seeing increased rodenticide adoption through government-led pest control programs aligned with urban expansion.

Key Market Trends

• Development of Third-Generation Anticoagulants: Environmental concerns over second-generation anticoagulant rodenticides (SGARs) — due to tissue persistence and harm to non-target wildlife — have prompted research into third-generation, eco-friendly formulations.
• Rise of Biological and Natural Rodenticides: Products like BIORAT, developed by Cuba's Biological Pharmaceutical Laboratories, represent a growing trend toward natural rodent control, currently available across 22 countries in Latin America, Africa, Asia, and Europe.

Regulatory Landscape

Stringent government regulations remain a key market restraint. In the U.S., all pesticides must be registered with the EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Restricted-use rodenticides — those potentially harmful even when label directions are followed — can only be applied by certified pest applicators, limiting market access.

Key Industry Players

Leading companies operating in the global rodenticides market include:

• BASF SE (Germany)
• Bayer AG (Germany)
• Neogen Corporation (U.S.)
• Rentokil Initial Plc (U.K.)
• Bell Laboratories Inc. (U.S.)
• PelGar International (U.K.)
• Liphatech, Inc. (U.S.)
• Syngenta AG (Switzerland)
• EcoClear Products Inc. (U.S.)
• Impex Europa (Spain)

Recent Industry Developments

• August 2019: BASF SE launched "Storm Ultra Secure", a new rodenticide containing 25 ppm of flocoumafen, targeting professional and amateur pest control users.
• November 2017: Rentokil Initial Plc acquired 100% of Vector Disease Acquisition, LLC, North America's largest mosquito control services provider, strengthening its regional presence.

`